Recombinant turkey herpesvirus candidate vaccine strain for expressing gene VII-type Newcastle disease virus fusion protein and preparation method thereof
A technology for turkey herpes virus and Newcastle disease virus, which is applied in the field of genetic engineering vaccines, can solve the problems such as the inability to effectively prevent the detoxification of infected birds and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Example 1: Construction of transfer vectors pFR-F and pFR-ΔF
[0034] 1. Cloning and identification of F gene of Newcastle disease virus strain (DT-2014)
[0035] 1.1 Primer design
[0036] Referring to the sequence of the F gene of the gene VII Newcastle disease virus DT-2014 strain (GenBank accession number: MN125616; Seq No.1), a pair of specific primers were designed with primer5.0 software, wherein the upstream primer contained the KOZAK sequence, and the downstream primer Remove the stop codon. The primer sequences are as follows:
[0037] NDF-F (Seq No.3): 5'-GCCACCATGGGCTCCAAACTTTTCTACC-3'
[0038] NDF-R (Seq No.4): 5'-TGCTCTTGTAGTGGCTCTCATCT-3'
[0039] 1.2 Construction of intermediate plasmid pM3-F
[0040] Take 200 μL of sterile allantois from NDV DT-2014 strain of gene type VII, extract RNA, use NDF-F / NDF-R as primers, and perform RT-PCR. After the reaction, perform 1% agarose gel electrophoresis to recover the F gene The bands, recovered product and ...
Embodiment 2
[0071] Example 2: Rescue and purification of recombinant viruses rHVT-NDV-VII-F and rHVT-NDV-VII-ΔF
[0072] 1. Expanded culture of recombinant virus rHVT-EGFP
[0073] The recombinant virus rHVT-EGFP was preserved and provided by the Key Open Laboratory of Livestock and Poultry Infectious Diseases, Ministry of Agriculture, Yangzhou University (Wu Yantao, et al. A recombinant turkey herpes virus strain expressing the HA gene of H9 subtype avian influenza virus. Patent application number: CN201710517830.5, application publication number: CN 107142280 A). The recombinant virus rHVT-EGFP stored in liquid nitrogen was revived, and the revived cell virus liquid was diluted 10 times with M199 medium containing 5% fetal bovine serum. Prepare the second-generation CEF and spread it on a 6-well cell culture plate. After culturing for 2 hours, inoculate the double-diluted virus solution, 900 μL per well, and culture it in a cell culture incubator. After 24 hours, discard the culture so...
Embodiment 3
[0093] Example 3: Evaluation of immune efficacy of recombinant viruses rHVT-NDV-VII-F and rHVT-NDV-VII-ΔF
[0094] 1. Immune protection test of recombinant virus
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com